Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4729 Target Snapshot

Cytochrome P450 2B6 · SINGLE PROTEIN · Homo sapiens

972Compounds
623Assays
16Approved Drugs
702.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P20813. Use UniProt P20813 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P20813 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome P450 2B6 as ChEMBL target CHEMBL4729, mapped to UniProt P20813. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome P450 2B6
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4729
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P20813
Cytochrome P450 2B6
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome P450 2B6 is the right protein anchor across sources, using UniProt P20813 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome P450 2B6
UniProt AccessionP20813
Component TypeProtein
Sequence Length491 aa

Cytochrome P450 2B6

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome P450 2B6, mapped to UniProt P20813. Sequence length is 491 aa.

Mapped IDP20813
Review nameCytochrome P450 2B6
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

16
Approved
5
Phase III
10
Phase II
Assay Mix

Activity Type Distribution

IC50638.0
KI54.0
EC5010.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4175869 7.22 IC50 60.0 Preclinical
CHEMBL4160749 7.21 IC50 62.0 Preclinical
CHEMBL4168669 7.14 IC50 73.0 Preclinical
CHEMBL4165249 7.06 IC50 87.0 Preclinical
CHEMBL4161819 7.03 IC50 93.0 Preclinical
CHEMBL4161400 6.92 IC50 120.0 Preclinical
CHEMBL4159065 6.75 IC50 180.0 Preclinical
CHEMBL833 6.7 Ki 200.0 Approved
CHEMBL833 6.68 IC50 210.0 Approved
CHEMBL4169324 6.64 IC50 230.0 Preclinical
Distribution

pChEMBL Value Distribution

83
5.0
24
5.5
17
6.0
5
6.5
5
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

CANNABIDIOL
CHEMBL190461
Approved 2018
VORICONAZOLE
CHEMBL638
Approved 2002
CLOPIDOGREL
CHEMBL1771
Approved 1997
TICLOPIDINE
CHEMBL833
Approved 1991
ETHINYL ESTRADIOL
CHEMBL691
Approved 1982
TAMOXIFEN
CHEMBL83
Approved 1977
Assay Landscape

Assay Landscape

623
Total Assays
246
Tested Compounds
2
Assay Types
ADME — 615 assays, 246 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 313 119 4.9
microsome format 153 109 5.2
assay format 70 11 5.0
cell-based format 70 7 5.8
tissue-based format 8 0
cell membrane format 1 0
Binding — 8 assays, 12 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 4 2 5.2
assay format 2 9 4.6
tissue-based format 2 1 4.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine